Alzheimer's disease treatment in 21 Oncology clinics in Germany

Top
Clinics
Ratings
Diseases
Quick navigation

21 clinics specializing in Oncology providing treatment of Alzheimer's disease Alzheimer's disease is a progressive neurological disorder that affects memory, thinking, and behavior. It leads to cognitive decline, memory loss, confusion, and may result in functional impairment as the disease advances. in Germany.

Aachen · 1
Dresden · 1
Erlangen · 1
Essen · 1
Hamburg · 3
Hannover · 1
Köln · 1
Magdeburg · 1
Munich · 3
Rostock · 1
Solingen · 1
Würzburg · 1
You can select a specific city
Aachen · 1 Dresden · 1 Düsseldorf · 1 Erlangen · 1 Essen · 1 Frankfurt am Main · 1 Göttingen · 1 Hamburg · 3 Hannover · 1 Heidelberg · 1 Köln · 1 Magdeburg · 1 Munich · 3 Regensburg · 1 Rostock · 1 Solingen · 1 Würzburg · 1
Sorted by:
Relevance
Rating Relevance
Prices for popular procedures:
  1. Monoclonal antibodies therapy (mAbs)
    by request
  2. Hemicolectomy
    ≈ $30,278
  3. Rectum anterior resection
    ≈ $22,399
  4. Radical prostatectomy
    ≈ $21,826
  5. Transurethral resection of the prostate (TURP)
    ≈ $9,678
  6. Conization
    ≈ $5,249
  7. Open hysterectomy
    ≈ $13,459
  8. Radical nephrectomy
    ≈ $31,204
  9. Loop electrosurgical excision procedure (LEEP)
    ≈ $3,093
photo
Göttingen, Germany
Specializations: Cardiac surgery, Vascular surgery, Thoracic surgery, Neurosurgery, Spine surgery, Orthopedic surgery, Oncology
Languages: English
The University Medicine Göttingen (UMG) is one of the leading university medical institutions in Germany. According to the advertising slogan, Göttingen is the "city that read more

Clinics grouping by rating

Clinic with the highest rating of 3.7 — Universitätsklinikum Carl Gustav Carus, Dresden in Dresden, Germany, clinic with the most reviews number of 1120 — Klinikum rechts der Isar der Technischen Universität München in Munich, Germany.

Countries with the highest number of clinics treating the diseases:

Alzheimer's disease:

Related procedures:

Procedures are likely to be used for Alzheimer's disease treatment: Monoclonal antibodies therapy (mAbs) .